Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

osteonecrosis of the jaw

  • You have access
    Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study
    KAKUHIRO YAMAGUCHI, TAKESHI MASUDA, KAZUNORI FUJITAKA, KEI MIWATA, SHINJIRO SAKAMOTO, YASUSHI HORIMASU, KOSUKE HAMAI, SHINTARO MIYAMOTO, TAKU NAKASHIMA, YOHEI OKAMOTO, HIROSHI IWAMOTO, NOBUHISA ISHIKAWA, YOSHIHIRO MIYATA, MORIHITO OKADA, HIRONOBU HAMADA and NOBORU HATTORI
    In Vivo September 2018, 32 (5) 1155-1160; DOI: https://doi.org/10.21873/invivo.11358
In Vivo

© 2026 In Vivo

Powered by HighWire